by McKesson Ventures | Apr 27, 2021 | Portfolio News
Forbes has released its third annual AI 50, a list of private, promising North American companies that are using artificial intelligence in ways that are fundamental to their operations, and McKesson Ventures portfolio company Komodo Health is among them. To be...
by McKesson Ventures | Mar 22, 2021 | Portfolio News
Komodo Health announced a $220 million Series E funding round led by Tiger Global Management and joined by Casdin Capital. Existing investors ICONIQ Growth, Andreesen Horowitz, and SVB Capital also participated in the round. The funding has propelled Komodo into the...
by McKesson Ventures | Jul 23, 2020 | Press Releases
Based on its recent analysis of the North American real-world evidence (RWE) solutions market in healthcare, Frost & Sullivan has recognized Komodo Health with the 2020 North American Company of the Year award. Komodo Health’s comprehensive real-time Healthcare...
by McKesson Ventures | May 12, 2020 | Portfolio News
A new report from Komodo Health shows that diagnostic testing for cancer and other conditions has declined across the U.S. since mid-March following regional lockdowns for the COVID-19 pandemic. Komodo Health analyzed billing records of 320 million patients from March...
by McKesson Ventures | May 8, 2020 | Portfolio News
Electronic health record software provider Epic released data indicating that appointments for cervix, colon, and breast cancer screenings have dropped between 86 percent and 94 percent compared to average volumes in the three years before the confirmation of the...
